Pre-Open Stock Movers:
Biodesix, Inc. (Nasdaq: BDSX) 55% HIGHER; sees insider buying from the Chairman and other members of the board.
Hoth Therapeutics , Inc. (NASDAQ:HOTH) 24% LOWER; prices 8,235,294 shares of common stock at a public offering price of $0.85 per share.
Myovant Sciences (NYSE:MYOV) (MYOV) 21% LOWER; The company and partner Pfizer (NYSE:PFE) (PFE) said the FDA provided notice to the companies that the agency identified deficiencies that preclude discussion of labeling and/or post-marketing requirements and commitments at this time.
TeraWulf Inc. (WULF) 15% LOWER; commencing an underwritten public offering of its common stock.
Aeglea BioTherapeutics, Inc. (Nasdaq: AGLE) 13% HIGHER; provided additional data from the PEACE Phase 3 study during a poster presentation at the Society for Inherited Metabolic Disorders (SIMD) Annual Meeting.
CrowdStrike Holdings (NASDAQ:CRWD) (CRWD) 6% HIGHER; Goldman Sachs (NYSE:GS) upgraded to Buy with a price target of $285.
CarMax (NYSE:KMX) (KMX) 5% LOWER; posted Q4 EPS of $0.98, below the analyst estimate of $1.33. Revenue was $7.7 billion versus the consensus estimate of $7.67 billion.
Kohl's (NYSE:KSS) 5% HIGHER; Franchise Group (NASDAQ:FRG) has joined the bidding for the retailer and is willing to pay $69 per share, Reuters said.
Veru Inc. (NASDAQ:VERU) 4% HIGHER; Adds to today's 182% intra-day gains on the back of positive COVID-19 trials.
Albertsons (ACI) 3% LOWER; posted Q4 EPS of $0.75, $0.12 better than the analyst estimate of $0.63. Revenue for the quarter came in at $17.4 billion versus the consensus estimate of $16.66 billion. The company is looking for FY2022 EPS of $2.70-$2.85, versus the consensus of $2.78.
Eton Pharmaceuticals , Inc (Nasdaq: NASDAQ:ETON) 2% LOWER; named James Gruber will replace Wilson Troutman as CFO.
Cardinal Health (NYSE:CAH) (CAH) 2% HIGHER; Morgan Stanley (NYSE:MS) upgraded to Overweight with a price target of $74.